Xing-Jie Liang Selected Research

mitaplatin

3/2012

Mitaplatin increases sensitivity of tumor cells to cisplatin by inducing mitochondrial dysfunction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xing-Jie Liang Research Topics

Disease

171	Neoplasms (Cancer) 02/2024 - 06/2003
22	Breast Neoplasms (Breast Cancer) 09/2023 - 01/2012
15	Neoplasm Metastasis (Metastasis) 02/2024 - 01/2010
11	Hyperthermia 01/2023 - 10/2012
10	Hypoxia (Hypoxemia) 02/2024 - 07/2014
6	Adenocarcinoma 11/2022 - 09/2003
5	COVID-19 01/2023 - 01/2022
5	Bacterial Infections (Bacterial Infection) 06/2022 - 11/2017
5	Prostatic Neoplasms (Prostate Cancer) 03/2016 - 04/2010
4	Melanoma (Melanoma, Malignant) 09/2023 - 04/2005
4	Rheumatoid Arthritis 03/2023 - 01/2019
4	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 03/2012
3	Wounds and Injuries (Trauma) 12/2023 - 01/2022
3	Pancreatic Neoplasms (Pancreatic Cancer) 11/2022 - 10/2019
3	Glioblastoma (Glioblastoma Multiforme) 08/2022 - 01/2019
3	Mitochondrial Diseases (Mitochondrial Disease) 01/2022 - 03/2012
3	Brain Neoplasms (Brain Tumor) 01/2022 - 05/2021
3	Glioma (Gliomas) 01/2022 - 04/2007
3	Adenocarcinoma of Lung 01/2019 - 10/2008
3	Carcinoma (Carcinomatosis) 11/2008 - 02/2004
2	Neuroinflammatory Diseases 02/2024 - 01/2020
2	Atherosclerosis 01/2023 - 12/2017
2	Virus Diseases (Viral Diseases) 01/2023 - 11/2021
2	Inflammation (Inflammations) 11/2022 - 11/2022
2	Chronic Disease (Chronic Diseases) 11/2022 - 10/2011
2	Atherosclerotic Plaque (Atheroma) 04/2022 - 01/2018
2	Metabolic Diseases (Metabolic Disease) 02/2022 - 11/2016

Drug/Important Bio-Agent (IBA)

25	Cisplatin (Platino)FDA LinkGeneric 12/2023 - 07/2003
19	Small Interfering RNA (siRNA)IBA 02/2024 - 09/2010
17	GoldIBA 06/2022 - 09/2010
13	Peptides (Polypeptides)IBA 11/2023 - 02/2012
13	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2023 - 05/2012
11	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2024 - 10/2008
11	MicellesIBA 01/2023 - 11/2012
11	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 09/2010
9	PolymersIBA 02/2024 - 04/2013
9	Proteins (Proteins, Gene)FDA Link 09/2023 - 04/2007
9	ProdrugsIBA 11/2022 - 05/2016
8	Therapeutic UsesIBA 11/2023 - 10/2011
7	LipidsIBA 12/2023 - 05/2016
7	PlatinumIBA 01/2023 - 09/2008
7	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2023 - 03/2016
7	LigandsIBA 01/2022 - 07/2013
7	EnzymesIBA 01/2022 - 10/2008
7	Silicon Dioxide (Silica)FDA LinkGeneric 01/2022 - 03/2014
6	VaccinesIBA 01/2023 - 01/2020
6	HydrogelsIBA 01/2023 - 04/2018
6	Glutathione (Reduced Glutathione)IBA 01/2022 - 01/2014
5	AntigensIBA 01/2022 - 01/2021
5	Drug CarriersIBA 01/2022 - 03/2015
4	Liposomes (Liposome)IBA 02/2024 - 05/2012
4	AntioxidantsIBA 12/2023 - 05/2014
4	Nucleic AcidsIBA 12/2023 - 03/2022
4	Dendrimers (Dendrons)IBA 01/2023 - 03/2015
4	AcidsIBA 08/2021 - 04/2019
4	Contrast MediaIBA 10/2020 - 11/2010
4	Methotrexate (Mexate)FDA LinkGeneric 01/2019 - 07/2003
4	homocamptothecinIBA 08/2018 - 07/2015
3	hydroxide ionIBA 10/2023 - 04/2010
3	IronIBA 01/2023 - 03/2018
3	Messenger RNA (mRNA)IBA 01/2023 - 12/2020
3	mRNA VaccinesIBA 01/2023 - 01/2022
3	Antineoplastic Agents (Antineoplastics)IBA 12/2022 - 10/2020
3	Photosensitizing Agents (Photosensitizers)IBA 04/2022 - 03/2016
3	Adenosine Triphosphate (ATP)IBA 01/2022 - 11/2016
3	NanocapsulesIBA 01/2022 - 01/2019
3	Transferrin (beta 2 Transferrin)IBA 01/2022 - 04/2010
3	Glucose (Dextrose)FDA LinkGeneric 08/2020 - 01/2019
3	Biomarkers (Surrogate Marker)IBA 01/2019 - 09/2011
3	Carbon Nanotubes (Carbon Nanotube)IBA 09/2014 - 12/2012
2	Carrier Proteins (Binding Protein)IBA 12/2023 - 03/2005
2	CarbonIBA 10/2023 - 01/2019
2	p21-Activated KinasesIBA 09/2023 - 09/2022
2	Glutamine (L-Glutamine)FDA Link 01/2023 - 01/2022
2	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 12/2022 - 10/2020
2	tocophersolanIBA 11/2022 - 08/2018
2	Tirapazamine (SR 4233)IBA 04/2022 - 01/2021
2	Chimeric Antigen ReceptorsIBA 01/2022 - 01/2022
2	mahuang-tangIBA 01/2022 - 12/2019
2	Cancer VaccinesIBA 01/2022 - 12/2020
2	Protein CoronaIBA 01/2022 - 01/2021
2	Nanoparticle Drug Delivery SystemIBA 01/2022 - 01/2017
2	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2022
2	RNA (Ribonucleic Acid)IBA 01/2022 - 04/2007
2	SurvivinIBA 01/2021 - 06/2020
2	Indicators and Reagents (Reagents)IBA 01/2021 - 03/2016
2	Glucose OxidaseIBA 01/2021 - 08/2020
2	phytochlorinIBA 01/2021 - 01/2021
2	NanovaccinesIBA 12/2020 - 01/2020

Therapy/Procedure

80	Therapeutics 02/2024 - 03/2005
29	Drug Therapy (Chemotherapy) 07/2023 - 07/2003
15	Immunotherapy 09/2023 - 01/2019
11	Photochemotherapy (Photodynamic Therapy) 01/2023 - 03/2013
11	Precision Medicine 04/2022 - 01/2017
10	Photothermal Therapy 10/2023 - 12/2012
9	Lasers (Laser) 09/2023 - 10/2016
7	Phototherapy (Light Therapy) 09/2023 - 10/2016
7	Radiotherapy 01/2022 - 09/2012
4	Induced Hyperthermia (Thermotherapy) 11/2020 - 01/2013
3	Intravenous Injections 03/2022 - 05/2012